Tag: preclinical trial

Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates

Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!

Coco the Koal is excited to be holding a Sponsored Research Agreement

G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬

We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.

It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.

Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨

Categories
Anti Cancer Cancer Treratments chemotherapy Fenbendazole Ivermectin Mebendazole Natural Treatments preclinical trial

A New Dawn: Courage Against Cancer Funds Its First Preclinical Trial on the Path to FDA Approval

Courage Against Cancer launches first preclinical trial of ivermectin and mebendazole against ovarian cancer

Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.